A novel Na+‐Independent alanine‐serine‐cysteine transporter 1 inhibitor inhibits both influx and efflux of D‐Serine
- 14 June 2016
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 94 (10) , 888-895
Abstract
NMDA receptor dysfunctions are hypothesized to underlie the pathophysiology of schizophrenia, and treatment with D‐serine (D‐Ser), an NMDA receptor coagonist, may improve the clinical symptoms of schizophrenia. Thus, upregulating the synaptic D‐Ser level is a novel strategy for schizophrenia treatment. Na+‐independent alanine‐serine‐cysteine transporter 1 (asc‐1) is a transporter responsible for regulating the extracellular D‐Ser levels in the brain. In this study, we discovered a novel asc‐1 inhibitor, (+)‐amino(1‐(3,5‐dichlorophenyl)‐3,5‐dimethyl‐1H‐pyrazol‐4‐yl)acetic acid (ACPP), and assessed its pharmacological profile. ACPP inhibited the D‐[3H]Ser uptake in human asc‐1‐expressing CHO cells and rat primary neurons with IC50 values of 0.72 ± 0.13 and 0.89 ± 0.30 μM, respectively. In accordance with the lower asc‐1 expression levels in astrocytes, ACPP did not inhibit D‐Ser uptake in rat primary astrocytes. In a microdialysis study, ACPP dose dependently decreased the extracellular D‐Ser levels in the rat hippocampus under the same conditions in which the asc‐1 inhibitor S‐methyl‐L‐cysteine (SMLC) increased it. To obtain insights into this difference, we conducted a D‐[3H]Ser efflux assay using asc‐1‐expressing CHO cells. ACPP inhibited D‐[3H]Ser efflux, whereas SMLC increased it. These results suggest that ACPP is a novel inhibitor of asc‐1.Keywords
Funding Information
- Takeda Pharmaceutical Company Limited
This publication has 27 references indexed in Scilit:
- In vitro Characterization of a small molecule inhibitor of the alanine serine cysteine transporter ‐1 (SLC7A10)Journal of Neurochemistry, 2013
- Increasing effects of S-methyl-l-cysteine on the extracellular d-serine concentrations in the rat medial frontal cortexAmino Acids, 2013
- The Dopamine Dysfunction in Schizophrenia Revisited: New Insights into Topography and Course2012
- Contributions of the d-serine pathway to schizophreniaNeuropharmacology, 2012
- d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in ratsBehavioural Brain Research, 2008
- A CSF and postmortem brain study of d-serine metabolic parameters in schizophreniaSchizophrenia Research, 2007
- Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patientsBMC Psychiatry, 2005
- Identification and Characterization of a Na+-independent Neutral Amino Acid Transporter That Associates with the 4F2 Heavy Chain and Exhibits Substrate Selectivity for Small Neutral d- and l-Amino AcidsJournal of Biological Chemistry, 2000
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in HumansArchives of General Psychiatry, 1994
- Increases in strychnine-insensiive glycine binding sites in cerebral cortex of chronic schizophrenics: Evidence for glutamate hypothesisBiological Psychiatry, 1994